Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
about
Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.FADS2 genotype regulates delta-6 desaturase activity and inflammation in human adipose tissueEpigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate LevelsAssociations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study.Interorgan cross talk between fatty acid metabolism, tissue inflammation, and FADS2 genotype in humans with obesity.Epigenetic alterations in blood mirror age-associated DNA methylation and gene expression changes in human liver.Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver.Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States.Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action.TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.NAFLD risk alleles in PNPLA3, TM6SF2, GCKR, and LYPLAL1 show divergent metabolic effects.Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD.Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
P2860
Q35850407-FCFE69B0-D359-4803-8A55-1EFFB9C69FC0Q36399231-E1D0681A-1582-423E-A871-8169319FECF1Q36433576-59544085-71EA-44F0-A3D5-D0D3AEB1FF4DQ36599680-9236F9C3-30BA-46C5-BBFB-6D88E3179BADQ37088653-B6CD197F-C285-4218-A163-661FD0F0A1CEQ37633361-F731E634-C53C-40D9-A2A7-5764E10F89E5Q38987574-9D2E9E58-15F9-4587-93B8-7637F3A461A7Q39136510-8DEE1074-1FF5-4591-AE99-A0A1E006D736Q41691573-80382B57-E5EC-4C00-BBCF-99CCBBEE7637Q42145719-882E563D-BDA3-4BB7-B2B0-E4D8660C9A36Q49487192-C1B83959-6DE7-4962-9F3D-AD02947ABEA3Q49608904-4D3414C1-DB0B-4C4C-8CDB-21205D5E8FF2Q49903283-ABE434C2-99BC-4CC3-B061-1DAA0B570E8BQ51271391-A1910087-3161-49C9-80AD-2DF401B4C591Q51271856-53DF5124-5A22-42AE-A40C-FBE5A23C1CE1Q51300509-C0BBA034-E162-4727-B118-345F6918E92EQ52323790-A8ACA478-D14A-4FBD-8ECA-0AED25ECB4BBQ55261432-3CB78AEC-1038-424A-8CEE-9DA4FBFCF52CQ58802369-B91F9C23-279C-4AB0-9DFE-28C348C219AD
P2860
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@ast
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@en
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@nl
type
label
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@ast
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@en
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@nl
prefLabel
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@ast
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@en
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@nl
P2093
P2860
P50
P356
P1476
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
@en
P2093
Helena Gylling
Marko Simonen
Mika Tiainen
Pasi Soininen
Pirjo Käkelä
Sari Venesmaa
Vesa Kärjä
Ville T Männistö
P2860
P304
P356
10.1194/JLR.P054387
P577
2014-10-24T00:00:00Z